Quantum Pharmaceutical

Information

Name

Type

Company

Roles

Supplier

Company Size

Sme

Company Number

Incorporation Date

Website

https://www.aseptics.co.uk/

Address

Quantum House, Hobson Industrial Estate, Burnopfield County, Durham,NE16 6EA

Burnopfield
NE16 6EA
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Quantum Pharmaceutical
Sign up free

Contracts awarded to Quantum Pharmaceutical

The contracts that Quantum Pharmaceutical have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 7 months ago

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

£608,000,000 Bids close: 11 months ago
Award

Published 7 months ago

CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer

Proposed NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)<br/>Tender Reference: CM/PHR/22/5686/01<br/> <br/>Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

£6

Quantum Pharmaceutical

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Quantum Pharmaceutical

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer

Contacts

Statistics (1 Year)